ArticleCureus2026
Development of National Diagnostic Reference Levels for Chest Computed Tomography in Georgia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computed tomography (CT) is an essential diagnostic modality in modern medicine; however, it is associated with relatively high radiation exposure. Optimizing radiation dose while maintaining diagnostic image quality remains a major priority in clinical practice. Diagnostic reference levels (DRLs) are internationally recommended tools for dose optimization, yet national DRLs for chest CT examinations have not previously been established in Georgia. The objective of this study is to assess radiation dose metrics from non-contrast chest CT examinations across medical institutions in Georgia and to establish preliminary national DRLs for adult and pediatric populations based on real-world clinical practice. A nationwide, multicenter observational study was conducted across 27 Georgian medical institutions. Dose data from 136 consecutive patients who underwent non-contrast chest CT examinations between November 2024 and August 2025 were retrospectively analyzed. Both adult and pediatric patients were included. Radiation dose indicators, including CT Dose Index Volume (CTDIvol) and Dose Length Product (DLP), were collected alongside patient anthropometric parameters. Dose distributions were stratified by body mass index (BMI). DRLs were derived using the 75th percentile methodology in accordance with recommendations from the International Commission on Radiological Protection (ICRP). Substantial inter-facility variability in CT radiation dose metrics was observed, reflecting differences in scanner technology, protocol design, and utilization of automatic exposure control (AEC) systems. BMI-stratified analysis enabled the derivation of realistic, country-specific reference values. The calculated 75th percentile values of CTDIvol and DLP served as the basis for defining preliminary national DRLs for non-contrast chest CT examinations in Georgia. This nationwide assessment demonstrates the feasibility and importance of establishing national DRLs for chest CT in Georgia. The proposed DRLs provide a practical framework for radiation dose optimization without compromising diagnostic quality. Adoption of national DRLs is expected to reduce unnecessary radiation exposure, support continuous quality improvement, and enhance patient safety. Future efforts should focus on periodic DRL updates, broader implementation of dose-optimization technologies, and expansion to additional CT examination types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.